Caryn G. McDowell
2019
In 2019, Caryn G. McDowell earned a total compensation of $1.2M as Senior Vice President, General Counsel and Corporate Secretary at Revance Therapeutics, a 54% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $179,109 |
|---|---|
| Option Awards | $499,635 |
| Salary | $409,380 |
| Stock Awards | $129,225 |
| Other | $11,444 |
| Total | $1,228,793 |
McDowell received $499.6K in option awards, accounting for 41% of the total pay in 2019.
McDowell also received $179.1K in non-equity incentive plan, $409.4K in salary, $129.2K in stock awards and $11.4K in other compensation.
Rankings
In 2019, Caryn G. McDowell's compensation ranked 8,311th out of 13,971 executives tracked by ExecPay. In other words, McDowell earned more than 40.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,311 out of 13,971 | 41st |
Division Manufacturing | 3,285 out of 5,695 | 42nd |
Major group Chemicals And Allied Products | 1,244 out of 2,194 | 43rd |
Industry group Drugs | 1,057 out of 1,880 | 44th |
Industry Pharmaceutical Preparations | 784 out of 1,392 | 44th |
Source: SEC filing on March 26, 2020.
McDowell's colleagues
We found five more compensation records of executives who worked with Caryn G. McDowell at Revance Therapeutics in 2019.
2019
Mark Foley
Revance Therapeutics
Chief Executive Officer
2019
L Browne
Revance Therapeutics
Chief Executive Officer
2019
Abhay Joshi
Revance Therapeutics
Chief Operating Officer
2019
Tobin Schilke
Revance Therapeutics
Chief Financial Officer
2019
Dustin Sjuts
Revance Therapeutics